Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,025 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.
Königsberg R, Zojer N, Ackermann J, Krömer E, Kittler H, Fritz E, Kaufmann H, Nösslinger T, Riedl L, Gisslinger H, Jäger U, Simonitsch I, Heinz R, Ludwig H, Huber H, Drach J. Königsberg R, et al. J Clin Oncol. 2000 Feb;18(4):804-12. doi: 10.1200/JCO.2000.18.4.804. J Clin Oncol. 2000. PMID: 10673522
Treatment of chronic myelogenous leukemia with interferon alfa-2c: response rate and toxicity in a phase II multicenter study. The Austrian Biological Response Modifier (BRM) Study Group.
Thaler J, Gastl G, Fluckinger T, Niederwieser D, Huber H, Seewann H, Silly H, Lang A, Abbrederis C, Gadner H, et al. Thaler J, et al. Semin Hematol. 1993 Jul;30(3 Suppl 3):17-9. Semin Hematol. 1993. PMID: 8235697 Clinical Trial. No abstract available.
1,025 results
Jump to page
Feedback